PER 34.1% 8.9¢ percheron therapeutics limited

For General Information, page-2089

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    Maybe it’s because we don’t have a gateway in the US market yet because of the needed tox study?

    You’d think we could still present though on the basis that the tox study is underway, and our gateway is planned to open.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.